<DOC>
	<DOCNO>NCT01456819</DOCNO>
	<brief_summary>This randomize single blind study aim compare efficacy intramuscular autologous bone marrow mononuclear cell plus mesenchymal stem cell implantation intramuscular autologous bone marrow mononuclear cell implantation patient chronic critical limb ischemia . Patients randomize two group equal number ; patient one group implant mononuclear cell mesenchymal stem cell , implant mononuclear cell area affect limb .</brief_summary>
	<brief_title>Intramuscular Mononuclear Cells Mesenchymal Stem Cells Transplantation Treat Chronic Critical Limb Ischemia</brief_title>
	<detailed_description>When long blood vessel supply blood arm legs become blocked ( ischemic ) , patient experience painful sensation calf walk slowly become excruciate painful rest . When condition worsens , patient able feel pain leg know small ulcer cut legs . As result , small ulcer go unnoticed becomes big sometimes become infected . In bad situation , infection might lead towards gangrene septicaemia . Severe rest pain and/or ulceration ischemic limb define state chronic critical limb ischemia point , amputation affect limb suggest . Conventional treatment include angioplasty/bypass operation remove blood vessel blockage restore blood supply , use prescribe medicine aid ulcer recovery clear infection debridement damaged/infected tissue . Some procedure perform multiple time . Amputation inevitable many case blood capillary correct restenosis vessel common . Cell therapy mononuclear cell mesenchymal stem cell bone marrow promise stem cell capable stimulate regenerate capillary blood vessel .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<criteria>Clinical diagnosis critical limb ischemia lead ischemic ulcer amputation indicate Not suitable , remain symptomatic despite angioplasty , bypass operation collateralization Contraindication epidural anesthesia bone marrow aspiration Contraindication contrast angiography Evidence neoplasia bone marrow diseases Any acute chronic communicable disease include Hepatitis B , Hepatitis C HIV Patients limit life expectancy ( &lt; 1 year ) Patients myocardial infarction stroke within 6 month Patients coronary intervention within 6 month Renal impairment indicate serum creatinine great two time upper limit normal range Liver impairment indicate serum aspartate transaminase alanine transaminase great two time upper limit normal Any comorbidity physician deem contraindication stem cell transplantation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>autologous</keyword>
	<keyword>bone marrow</keyword>
	<keyword>critical limb ischemia</keyword>
	<keyword>efficacy</keyword>
	<keyword>mesenchymal stem cell</keyword>
	<keyword>mononuclear cell</keyword>
</DOC>